← The Wire
CRDFNasdaq
Cardiff Oncology, Inc.
Biological Products, (No Diagnostic Substances) · DE · CIK 1213037
Developing novel cancer therapies by targeting PLK1 inhibition with onvansertib and standard treatments
red 8-K · 90d
$105M
Market cap
$1.27
Last close
+1.6%
1D
-2.3%
5D
945K
Volume
Price · last 39 sessions-23.0%
May 4L $1.18 · H $1.94Jun 29
564
Total filings
Jun 11, 2026
Last filing
12/31
Fiscal year end
8-KShareholder VoteJun 11, 20268-KReg FD DisclosureJun 3, 20268-KMaterial AgreementMay 29, 20268-KCompany UpdateMay 19, 20268-KResults of OperationsMay 14, 202610-Q10-QMay 14, 2026DEFA14ADEFA14AApr 23, 2026DEF 14ADEF 14AApr 23, 20268-KExecutive Change · Company UpdateApr 9, 20268-KExecutive Change · Material AgreementApr 2, 20268-KReg FD DisclosureFeb 25, 20268-KAcquisition / DispositionFeb 24, 202610-K10-KFeb 24, 20268-KExecutive Change · Company UpdateJan 27, 20268-KResults of OperationsNov 6, 202510-Q10-QNov 6, 20258-KResults of Operations · Reg FD DisclosureJul 29, 202510-Q10-QJul 29, 20258-KShareholder VoteJun 26, 20258-KExecutive Change · Company UpdateJun 17, 20258-KResults of OperationsMay 8, 202510-Q10-QMay 8, 2025DEFA14ADEFA14AApr 30, 2025DEF 14ADEF 14AApr 29, 20258-KResults of OperationsFeb 27, 202510-K10-KFeb 27, 20258-KBylaw AmendmentJan 6, 2025424B5424B5Dec 11, 20248-KMaterial Agreement · Company UpdateDec 10, 20248-KReg FD Disclosure · Company UpdateDec 10, 2024SC 13GSC 13GNov 8, 20248-KResults of OperationsNov 7, 202410-Q10-QNov 7, 2024SC 13GSC 13GOct 24, 20248-KResults of OperationsAug 8, 202410-Q10-QAug 8, 20248-KShareholder VoteJun 20, 2024DEFA14ADEFA14AJun 17, 2024DEFA14ADEFA14AJun 3, 20248-KBylaw Amendment · Company UpdateJun 3, 20248-KResults of OperationsMay 2, 202410-Q10-QMay 2, 2024DEFA14ADEFA14AApr 25, 2024DEF 14ADEF 14AApr 25, 20248-KReg FD DisclosureApr 8, 20248-KResults of Operations · Reg FD DisclosureFeb 29, 202410-K10-KFeb 29, 20248-KReg FD DisclosureJan 8, 20248-KResults of Operations · Reg FD DisclosureNov 2, 202310-Q10-QNov 2, 20238-KReg FD Disclosure · Company UpdateSep 26, 20238-KResults of Operations · Bylaw AmendmentAug 9, 202310-Q10-QAug 9, 20238-KReg FD Disclosure · Company UpdateAug 7, 20238-KCompany UpdateJul 24, 20238-KCompany UpdateJun 20, 20238-KShareholder VoteJun 15, 20238-KResults of OperationsMay 4, 202310-Q10-QMay 4, 2023DEFA14ADEFA14AApr 27, 2023DEF 14ADEF 14AApr 27, 20238-KReg FD DisclosureMar 10, 20238-KResults of OperationsMar 2, 202310-K10-KMar 2, 20238-KExecutive Change · Company UpdateFeb 2, 2023SC 13GCARDIFF ONCOLOGY, INC.Jan 26, 20238-KResults of OperationsNov 3, 202210-Q10-QNov 3, 20228-KReg FD DisclosureOct 3, 20228-KReg FD Disclosure · Company UpdateSep 12, 20228-KCompany UpdateSep 6, 20228-KResults of OperationsAug 4, 202210-Q10-QAug 4, 2022SC 13GSC 13GJul 8, 20228-K/AShareholder VoteJun 14, 20228-KShareholder VoteJun 9, 20228-KResults of OperationsMay 5, 202210-Q10-QMay 5, 2022DEFA14ADEFA14AApr 15, 2022DEF 14ADEF 14AApr 14, 2022
Similar companies
Comparable business profile · signals at a glance